Feb. 18 at 8:34 PM
$SPRO a brilliant guy at the helm of a very focused most innovative bp leader.... Tony Wood, Chief Scientific Officer, GSK, said: “I’m delighted to combine GSK’s leadership in antimicrobial science with world-leading research at Imperial College London. Together, with scaled datasets, emerging drug modalities and AI-driven models, we will open up new approaches for the discovery of novel antibiotics as well as anticipate and outpace the development of resistance to transform the treatment and prevention of serious infections. Currently, GSK has a promising portfolio of relevant assets in development, many targeting pathogens identified as priorities by WHO and US CDC. We will continue to be a leader in inspiring much more collective action, across industry, academia and policy and I believe our partnership with the Fleming Initiative is an important new step in that direction.”
https://www.gsk.com/en-gb/media/press-releases/gsk-and-fleming-initiative-scientists-unite-to-target-amr-with-advanced-ai/
